Veeva Systems Research and Development Expenses 2012-2025 | VEEV
Veeva Systems annual/quarterly research and development expenses history and growth rate from 2012 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Veeva Systems research and development expenses for the quarter ending April 30, 2025 were $0.184B, a 13.1% increase year-over-year.
- Veeva Systems research and development expenses for the twelve months ending April 30, 2025 were $0.714B, a 10.8% increase year-over-year.
- Veeva Systems annual research and development expenses for 2025 were $0.693B, a 10.18% increase from 2024.
- Veeva Systems annual research and development expenses for 2024 were $0.629B, a 20.9% increase from 2023.
- Veeva Systems annual research and development expenses for 2023 were $0.52B, a 36.19% increase from 2022.
| Veeva Systems Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025 | $693 |
| 2024 | $629 |
| 2023 | $520 |
| 2022 | $382 |
| 2021 | $294 |
| 2020 | $210 |
| 2019 | $159 |
| 2018 | $132 |
| 2017 | $97 |
| 2016 | $66 |
| 2015 | $41 |
| 2014 | $26 |
| 2013 | $15 |
| 2012 | $8 |
| 2011 | $4 |
| Veeva Systems Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-04-30 | $184 |
| 2025-01-31 | $182 |
| 2024-10-31 | $172 |
| 2024-07-31 | $176 |
| 2024-04-30 | $163 |
| 2024-01-31 | $164 |
| 2023-10-31 | $161 |
| 2023-07-31 | $157 |
| 2023-04-30 | $147 |
| 2023-01-31 | $143 |
| 2022-10-31 | $130 |
| 2022-07-31 | $134 |
| 2022-04-30 | $113 |
| 2022-01-31 | $105 |
| 2021-10-31 | $99 |
| 2021-07-31 | $95 |
| 2021-04-30 | $83 |
| 2021-01-31 | $82 |
| 2020-10-31 | $80 |
| 2020-07-31 | $70 |
| 2020-04-30 | $62 |
| 2020-01-31 | $61 |
| 2019-10-31 | $53 |
| 2019-07-31 | $51 |
| 2019-04-30 | $45 |
| 2019-01-31 | $43 |
| 2018-10-31 | $40 |
| 2018-07-31 | $39 |
| 2018-04-30 | $37 |
| 2018-01-31 | $37 |
| 2017-10-31 | $34 |
| 2017-07-31 | $33 |
| 2017-04-30 | $28 |
| 2017-01-31 | $26 |
| 2016-10-31 | $25 |
| 2016-07-31 | $24 |
| 2016-04-30 | $22 |
| 2016-01-31 | $20 |
| 2015-10-31 | $18 |
| 2015-07-31 | $15 |
| 2015-04-30 | $13 |
| 2015-01-31 | $12 |
| 2014-10-31 | $11 |
| 2014-07-31 | $10 |
| 2014-04-30 | $9 |
| 2014-01-31 | $8 |
| 2013-10-31 | $7 |
| 2013-07-31 | $6 |
| 2013-04-30 | $6 |
| 2013-01-31 | |
| 2012-10-31 | $4 |
| 2012-01-31 | |
| 2011-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $43.991B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $13.179B | 0.00 |
| Doximity (DOCS) | United States | $12.725B | 56.62 |
| Hims & Hers Health (HIMS) | United States | $9.572B | 78.43 |
| IRhythm Technologies (IRTC) | United States | $5.461B | 0.00 |
| Hinge Health (HNGE) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $2.828B | 209.46 |
| Inspire Medical Systems (INSP) | United States | $2.771B | 40.74 |
| Heartflow (HTFL) | $2.557B | 0.00 | |
| Phreesia (PHR) | United States | $1.884B | 0.00 |
| Enovis (ENOV) | United States | $1.766B | 9.34 |
| 10x Genomics (TXG) | United States | $1.744B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 28.84 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Claritev (CTEV) | United States | $1.135B | 0.00 |
| Evolent Health (EVH) | United States | $1.134B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.679B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.652B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.481B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.405B | 0.00 |
| Carlsmed (CARL) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.53 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.239B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.234B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.175B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| CareCloud (CCLD) | United States | $0.163B | 7.38 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |